Biodesix grows earnings but misses Wall Street expectations Tim August 11, 2021 BOULDER — The good news for lung cancer diagnostics developer Biodesix Inc. (Nasdaq: BDSX) was that the company grew year-over-year […] Source: BizWest
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development. View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving… Tim December 2, 2022
Biodesix expects significant sales growth in third quarter BOULDER — Biodesix Inc. (Nasdaq: BDSX), a Boulder-headquartered life-sciences company that specializes in developing tools to detect lung disease, is… Tim October 11, 2022
Boulder biotech firm Biodesix leases former Kohl’s store in Louisville LOUISVILLE — Cancer diagnostics and khaki shorts. The pair of words doesn’t really fit together in any meaningful context —… Tim October 6, 2022
Biodesix offers new shares to bolster credit line BOULDER — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, has launched… Tim November 18, 2022
Biodesix losses grow with pivot from COVID-19 testing BOULDER — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, saw its… Tim March 6, 2023